Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.
Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.
Braune SA, et al. Among authors: kluge s.
Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.
Crit Care Med. 2013.
PMID: 23660733